• logo
  • CanadaCanada
  • Products
    • Search for Product
      • Product Name

        Keyword Search

    • Featured Products
        • LINCOMED 100

          LincoMed 100

        • FERROFORTE

          FERROFORTE

  • News
  • Library
  • Facilities
  • Regions
  • Contacts

Corporate Social Responsibility

  • Health and Safety at Bimeda Canada
    Health and Safety at Bimeda Canada

    Globally, Bimeda is dedicated to health and safety, and to ensuring a safe, happy and healthy working environment for everyone. The team in Canada share this commitment, and understand the vital role that training plays in ensuring a safe working environment. With this in mind, earlier in the year, Bimeda Canada organised some great health and safety training for managers, supervisors and lead hands. Leaders were trained on their roles and responsibilities in relation sustaining a healthy and safe working environment.

    All employees successfully participated in Health and Safety in Four Steps training, and learned about the new Globally Harmonized System which was created to harmonize hazard classification criteria and chemical hazard communication elements worldwide.

In The News

Bimeda-MTC announces the addition of TilcoMed to their line-up.

Cambridge, Ontario (July 20, 2015): now available from Bimeda-MTC: TilcoMed (Tilmicosin Injection USP, 300 mg/mL) an antibiotic to treat Bovine Respiratory Disease in beef cattle as well as Pneumonic Pasteurellosis in lambs. DIN 02435861, Approved by Health Canada.

TilcoMed is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia (Pasturella) haemolytica and Pasteurella multocida. For the reduction of morbidity associated with bovine respiratory disease (BRD) in feedlot calves, caused by Mannheimia (Pasturella) haemolytica and Pasteurella multocida, during the first 30 days in the feedlot, when administered at the time of arrival.

Also for the treatment of pneumonic pasteurellosis in lambs associated with Mannheimia (Pasteurella) haemolytica.

Not intended for use in lactating dairy cows.

Cautions:
Do not administer intravenously.

Do not administer to swine. Injection can be fatal.

Not for human use. Human injection has been associated with fatalities.

For further information visit www.bimedamtc.com or email This email address is being protected from spambots. You need JavaScript enabled to view it.

Subscribe to our RSS News Feed feed